Tyra Biosciences, Inc.
Tyra Biosciences, Inc. scores highest on Torque (61) and lowest on Price (18). Its PosiPenta is 40.29 out of 100, around the middle of similar companies.
On the Penta Grid this week, Tyra Biosciences, Inc. is Grid #533 of 837 in the Healthcare sector in United States, and Grid #2,856 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Tyra Biosciences, Inc. | 40.29 | 18 | 23 | 44 | 61 | 54 |
| AnaptysBio, Inc. | 41.18 | 0 | 74 | 69 | 0 | 63 |
| Eton Pharmaceuticals, Inc. | 58.40 | 5 | 88 | 81 | 61 | 56 |
| Inhibrx Biosciences, Inc. | 26.33 | 0 | 16 | 64 | 2 | 50 |
| Pacira BioSciences, Inc. | 66.05 | 32 | 88 | 99 | 52 | 58 |
| Ocular Therapeutix, Inc. | 35.41 | 22 | 31 | 35 | 42 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -7.75 |
| P/B ratio | 3.60 |
EEarnings
| Trailing EPS | ₹-226.37 |
| Forward EPS | ₹-262.42 |
NNitro
| Price | 1754.12 |
| 52-week high | 3850.16 |
| 52-week low | 1264.44 |
| Fall from 52-week high | 54.4% |
TTorque
| Return on equity (ROE) | -45.31% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 0.75 |
| Market cap | ₹12,060 Cr |
| Insider holding | 2.43% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Tyra Biosciences, Inc.'s PosiPenta score?
Tyra Biosciences, Inc.'s PosiPenta is 40.29 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Tyra Biosciences, Inc. stand on the Penta Grid?
On the Penta Grid this week, Tyra Biosciences, Inc. is Grid #533 of 837 in the Healthcare sector in United States, and Grid #2,856 of 4,000 in United States.
Which PosiPenta pillar is strongest for Tyra Biosciences, Inc.?
Torque (durability), with a score of 61 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Tyra Biosciences, Inc.?
Price (valuation), with a score of 18 out of 100: much weaker than most similar companies.
Has Tyra Biosciences, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.66 points, from 36.63 to 40.29.
PositoAI is for research and education only and is not investment advice.